Price Chart

Profile

Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer. The company aims to disrupt conventional approaches to CAR-T cell therapies with its proprietary technology platforms-FasTCAR and TruUCAR.
URL https://www.gracellbio.com
Investor Relations URL https://ir.gracellbio.com/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 13, 2024 (est.)
Last Earnings Release Nov. 13, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer. The company aims to disrupt conventional approaches to CAR-T cell therapies with its proprietary technology platforms-FasTCAR and TruUCAR.
URL https://www.gracellbio.com
Investor Relations URL https://ir.gracellbio.com/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 13, 2024 (est.)
Last Earnings Release Nov. 13, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A